Ribang Instrumental Roadshow attracts attention with five major advantages

The launch of the first road show of Libang Instrument was launched in Beijing. The five strengths of the company's development of the GEM are highly concerned by the institutions and the industry.

At the beginning of the establishment of the GEM, “high-tech” was one of the requirements of the company, and this indicator relied on strong research and development advantages. Libang instrument prospectus disclosure, the company has a highly professional and highly qualified R & D team, the proportion of personnel up to 30.56%, the company's project average development cycle of 12 months, product development and a success rate of 93%. According to the company's top management, on the basis of Xi'an Libang and Libang Diagnostics, the company will also use fund-raising to expand the R&D center to keep up with the global leading technology trends and achieve a global strategy for R&D deployment. From the prospectus and the Shenzhen Medical Device Industry Report, the company’s investment in research and development expenses for the past three years has maintained a level of about 12%, which is the leading position in the industry.

The state-of-the-art marketing advantage of Libang Instrument is also quite eye-catching. As of December 31, 2010, the company has 23 offices across the country, with more than 2,400 domestic distributors, covering more than 2,000 counties and cities in China and more than 480 general hospitals above grade 3; with 1,166 international distributors , covering more than 120 countries and regions around the world. Industry analysts believe that: "Libang Instrument has completed the global strategic layout. With the sinking of existing channels, once the market is opened, high-speed growth can be achieved. In the future, the promotion of the global market will have a significant point effect."

From the prospectus, the company’s product advantage is also a big weight for future competition. According to the disclosure, the company currently has four series, more than 20 varieties and more than 80 models of different grades of products, which can fully meet the different needs of different countries and levels of customers on product features and prices. Among them, Libang's obstetrics products have won the top spot in the domestic market, with a market share of 21.89% in 2009. An agency researcher believes that Ribang Instruments and Hitachi are among the second-tier companies in the industry. Although there are still gaps between high-end brands such as Philips, some of their product lines already have the ability to compete with top brands and have higher levels. With the advantage of price/performance ratio, with the further improvement of brand influence, the company's revenue and gross profit and other indicators will achieve further leaps.

Libang's brand and management advantages are two other aspects of the company. After nearly 15 years of development, the brand influence of Ribang’s perfection has gradually emerged. At present, the company has clients including the world's top medical institutions including the Royal Moroccan Hospital of Morocco, the Hong Kong Mary Hospital and the Malmö University Affiliated Hospital in Sweden, and has a strong international brand influence. At the same time, there are more than 480 companies in the 600 or more hospitals in China. In terms of management, the company's core management team is well-established. The three founders have worked in the industry for more than 20 years. They have experience in the medical device industry and have a strong academic background. Some of the directors have experience in international companies such as McKinsey and Siemens. The company's international business operations lay a good foundation.